Zithromax citizen petition on hold
Executive Summary
FDA has yet to resolve issues raised in Pfizer's Feb. 9 1citizen petition seeking the recall of Teva and Sandoz' generic azithromycin. FDA has been unable to reach a decision due to "complex issues requiring extensive review and analysis," FDA's 2response states. Pfizer claims the generics are misbranded "with respect to the polymorphic form of azithromycin they contain" (3"The Pink Sheet" Feb 27, 2006, p. 6)...
You may also be interested in...
FDA Approves Generic Of GSK Flonase But Launch Halted By Restraining Order
FDA's approval of generic Flonase has prompted a lawsuit by GlaxoSmithKline representing another challenge by brand manufacturers to the legitimacy of FDA-approved generic drugs
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.